Common Ophthalmic Preservatives in Soft Contact Lens Care Products: Benefits, Complications, and a Comparison to Non-Preserved Solutions.

IF 1.4 Q3 OPHTHALMOLOGY Clinical Optometry Pub Date : 2021-09-07 eCollection Date: 2021-01-01 DOI:10.2147/OPTO.S235679
Chelsea S Bradley, Lindsay A Sicks, Andrew D Pucker
{"title":"Common Ophthalmic Preservatives in Soft Contact Lens Care Products: Benefits, Complications, and a Comparison to Non-Preserved Solutions.","authors":"Chelsea S Bradley,&nbsp;Lindsay A Sicks,&nbsp;Andrew D Pucker","doi":"10.2147/OPTO.S235679","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Preservatives are essential for preventing contact lens (CL)-related microbial keratitis (MK). The purpose of this review is to summarize the current knowledge related to the use of common ophthalmic preservatives in CL care products with respect to both safety and efficacy.</p><p><strong>Methods: </strong>Manuscripts written in English were obtained by searching PubMed.gov with the term contact lens plus antimicrobial, benzalkonium chloride, biguanide, Aldox, polyquaternium, preservative, thimerosal, EDTA (ethylenediaminetetraacetic acid), chlorhexidine, or blister pack.</p><p><strong>Results: </strong>This review found that first-generation preservatives are no longer used in CL multipurpose solutions (MPS) due to their high levels of ocular toxicity. Modern, high-molecular-weight preservatives, including polyquaternium-1 (PQ-1) and biguanides (PHMB), are generally effective against bacteria, minimally effective against fungi, and not effective against <i>Acanthamoeba</i>. PQ-1 and PHMB are likely safe when used with CLs, but they may cause ocular adverse events, with roughly equal risk between the two preservatives. Some CL MPS contain both PQ-1 and PHMB, but no increased risk of adverse events has been reported when combining the two. Hydrogen-peroxide (H<sub>2</sub>O<sub>2</sub>) solutions are effective against all common ocular microbes, including <i>Acanthamoeba</i>, and they have been proven safe with proper compliance. Povidone-iodine (P-I) solutions are not currently commercially available in North America, but they have been shown in other countries to be safe and effective.</p><p><strong>Conclusion: </strong>Patients should be monitored when using PQ-1 or PHMB-containing solutions since they have been associated with ocular adverse events. If events are detected, patients should be switched to an alternative solution. H<sub>2</sub>O<sub>2</sub> or P-I solutions are preferred for any patient who may expose their CLs to water because they are the only solution categories effective against <i>Acanthamoeba</i>.</p>","PeriodicalId":43701,"journal":{"name":"Clinical Optometry","volume":"13 ","pages":"271-285"},"PeriodicalIF":1.4000,"publicationDate":"2021-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/51/1d/opto-13-271.PMC8434857.pdf","citationCount":"9","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Optometry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/OPTO.S235679","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 9

Abstract

Purpose: Preservatives are essential for preventing contact lens (CL)-related microbial keratitis (MK). The purpose of this review is to summarize the current knowledge related to the use of common ophthalmic preservatives in CL care products with respect to both safety and efficacy.

Methods: Manuscripts written in English were obtained by searching PubMed.gov with the term contact lens plus antimicrobial, benzalkonium chloride, biguanide, Aldox, polyquaternium, preservative, thimerosal, EDTA (ethylenediaminetetraacetic acid), chlorhexidine, or blister pack.

Results: This review found that first-generation preservatives are no longer used in CL multipurpose solutions (MPS) due to their high levels of ocular toxicity. Modern, high-molecular-weight preservatives, including polyquaternium-1 (PQ-1) and biguanides (PHMB), are generally effective against bacteria, minimally effective against fungi, and not effective against Acanthamoeba. PQ-1 and PHMB are likely safe when used with CLs, but they may cause ocular adverse events, with roughly equal risk between the two preservatives. Some CL MPS contain both PQ-1 and PHMB, but no increased risk of adverse events has been reported when combining the two. Hydrogen-peroxide (H2O2) solutions are effective against all common ocular microbes, including Acanthamoeba, and they have been proven safe with proper compliance. Povidone-iodine (P-I) solutions are not currently commercially available in North America, but they have been shown in other countries to be safe and effective.

Conclusion: Patients should be monitored when using PQ-1 or PHMB-containing solutions since they have been associated with ocular adverse events. If events are detected, patients should be switched to an alternative solution. H2O2 or P-I solutions are preferred for any patient who may expose their CLs to water because they are the only solution categories effective against Acanthamoeba.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
软接触镜护理产品中常见的眼科防腐剂:益处、并发症和与非保存溶液的比较。
目的:防腐剂是预防与隐形眼镜(CL)相关的微生物角膜炎(MK)所必需的。本综述的目的是总结目前的知识有关使用常见的眼科防腐剂在CL护理产品的安全性和有效性。方法:通过检索PubMed.gov获得英文稿件,检索词为:隐形眼镜加抗菌药物、苯扎氯铵、双胍、醛还原、聚季铵盐、防腐剂、硫柳汞、乙二胺四乙酸、氯己定或吸塑包装。结果:本综述发现第一代防腐剂由于其高水平的眼部毒性而不再用于CL多用途溶液(MPS)。现代的高分子量防腐剂,包括聚季铵盐-1 (PQ-1)和双胍类防腐剂(PHMB),通常对细菌有效,对真菌效果最低,对棘阿米巴没有效果。PQ-1和PHMB与CLs一起使用时可能是安全的,但它们可能引起眼部不良事件,两种防腐剂之间的风险大致相等。一些CL MPS同时含有PQ-1和PHMB,但合并两者时未见不良事件风险增加的报道。过氧化氢(H2O2)溶液对所有常见的眼部微生物都有效,包括棘阿米巴原虫,并且已被证明是安全的。聚维酮-碘(P-I)溶液目前在北美尚未商业化,但在其他国家已证明是安全有效的。结论:患者在使用PQ-1或含有phmb的溶液时应进行监测,因为它们与眼部不良事件有关。如果检测到事件,应将患者切换到替代解决方案。对于可能将CLs暴露于水的患者,H2O2或P-I溶液是首选,因为它们是唯一对棘阿米巴有效的溶液类别。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Clinical Optometry
Clinical Optometry OPHTHALMOLOGY-
CiteScore
3.00
自引率
5.90%
发文量
29
审稿时长
16 weeks
期刊介绍: Clinical Optometry is an international, peer-reviewed, open access journal focusing on clinical optometry. All aspects of patient care are addressed within the journal as well as the practice of optometry including economic and business analyses. Basic and clinical research papers are published that cover all aspects of optics, refraction and its application to the theory and practice of optometry. Specific topics covered in the journal include: Theoretical and applied optics, Delivery of patient care in optometry practice, Refraction and correction of errors, Screening and preventative aspects of eye disease, Extended clinical roles for optometrists including shared care and provision of medications, Teaching and training optometrists, International aspects of optometry, Business practice, Patient adherence, quality of life, satisfaction, Health economic evaluations.
期刊最新文献
Knowledge, Attitude, and Perception of African Optometrists on Fellowship of the American Academy of Optometry (AAO): A Cross-Sectional Survey. A Novel Optometry-Led Decision-Making Community Referral Refinement Scheme for Neovascular Age-Related Macular Degeneration Screening. Comparison of Samfilcon A and Balafilcon A Bandage Contact Lenses in Reducing Postoperative Symptoms After Pterygium Surgery. How Can We Better Inform Patients of the Importance of Contact Lens Compliance?: Current Perspectives. Comparison of the Diagnosis and Management of Demodex Blepharitis Between Eye Care Practitioners in India and Australasia - A Survey-Based Comparison.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1